Publications

Search our bibliography using the filters on the right-hand side.

Displaying 101 through 150 of 216 publications.

Hartman EE, Pawaskar M, Williams V, McLeod L, Dubois D, Benninga MA, Joseph A. Psychometric properties of PedsQL generic core scales for children with functional constipation in the Netherlands. J Pediatr Gastroenterol Nutr. 2014 Dec;59(6):739-47. doi: 10.1097/MPG.0000000000000527

Coles TM, Chen W, Nelson LM, Williams VS, Williams NJ, McLeod LD. Current sample size practices in the psychometric evaluation of patient-reported outcome measures for use in clinical trials. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam.

Chen W, McLeod LD, Coles TM. Rasch first? Factor first? Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands.

Kontoudis I, Harries M, Mohr P, Grange F, Ehness R, Benjamin L, Siakpere O, Barth J, Stapelkamp C, Pfersch S, McLeod LD, Kaye JA, Wolowacz SE. Economic burden of melanoma in three European countries: a retrospective observational study. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands.

Elewski B, McLeod L, Zhao Y, Mallya U, Lewbhol M. Secukinumab versus placebo or etanercept on time to response on patient-reported psoriasis symptoms of pain, itching, and scaling (FIXTURE study). Poster presented at the Society of Dermatology Physicians Assistants Fall Dermatology Conference; November 2014. San Diego, CA. Previously presented at the 72nd Annual Meeting of the American Academy of Dermatology. doi: 10.1016/j.jaad.2014.01.781

Elewski B, McLeod LD, Zhao Y, Mallya U, Lebwohl M. Secukinumab versus placebo or etanercept on time to response on patient-reported psoriasis symptoms of pain, itching, and scaling (FIXTURE Study). Poster presented at the 15th Annual Las Vegas Dermatology Seminar; October 30, 2014. Las Vegas, NV. Previously presented at the 72nd Annual Meeting of the American Academy of Dermatology.

Elewski B, McLeod LD, Zhao Y, Mallya U, Lebwohl M. Secukinumab versus placebo or etanercept on time to response on patient-reported psoriasis symptoms of pain, itching, and scaling (FIXTURE Study). Poster presented at the 33rd Anniversary Fall Clinical Dermatology Conference; October 16, 2014. Las Vegas, NV. Previously presented at the 72nd Annual Meeting of the American Academy of Dermatology.

McLeod LD, Mallya UG, Fox T, Strober B. Psoriasis patients with PASI90 response achieve greater health-related quality of life improvements than those with PASI75 response. Poster presented at the 23rd European Academy of Dermatology and Venereology Congress; October 8, 2014.

Mohr P, Harries M, Grange F, Ehness R, Benajmin L, Siakpere O, McLeod LD, Wolowacz SE, Kaye JA, Kontoudis I. Treatment patterns and disease burden of stage IIIB/IIIC melanoma in France, Germany and the UK. Poster presented at the ESMO 2014 Congress; September 28, 2014. Madrid, Spain. [abstract] Ann Oncol. 2014 Sep 1; 25(suppl 4):iv389. doi: 10.1093/annonc/mdu344.40

McLeod L. Review of the Task Force Report on PRO data collection in clinical trials using mixed modes. Value Health. 2014 Jul;17(5):491-2. doi: 10.1016/j.jval.2014.06.003

Webb S, Ware JE, Forsythe A, Yang M, Badia X, Nelson LM, Signorovitch JE, McLeod L, Maldonado M, Zgliczylski W, De Block C, Portocarrero-Ortiz L, Gadelha MR. Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing's disease. Eur J Endocrinol. 2014 Jul;171(1):89-98. doi: 10.1530/EJE-13-1013

Chen WH, McLeod L, Nelson LM, Williams VS, Fehnel SE. Quantitative challenges facing patient-centered outcomes research. Expert Rev Pharmacoecon Outcomes Res. 2014 Jun 14;14(3):379-86.

Chen WH, Nelson L, McLeod LD, Edelen MO. Quantitative challenges facing patient-centered outcomes research. Presented at the 2014 ISPOR 19th Annual International Meeting; June 4, 2014.

Strober B, Zhao Y, Tran MH, Gnanasakthy A, Nelson LM, McLeod LD, Mordin M, Gottlieb A, Elewski B, Lebwohl MG. Psychometric evaluation of the Psoriasis Symptom Diary using phase 3 trial data. Poster presented at the 2014 ISPOR 19th Annual International Meeting; May 2014. Montreal, Canada. [abstract] Value Health. 2014 Jun; 17(3):A288. doi: 10.1016/j.jval.2014.03.1676

Coles T, Coon C, DeMuro C, McLeod LD, Gnanasakthy A. Psychometric evaluation of the Sheehan Disability Scale in adult patients with attention-deficit/hyperactivity disorder. Neuropsychiatr Dis Treat. 2014 May 19;10:887-95. doi: 10.2147/NDT.S55220. eCollection 2014

DeMuro CJ, McLeod LD, Fehnel SE, Meyer T. Determining clinically meaningful change in subjective tinnitus loudness. Presented at the 2014 International Tinnitus Seminar; May 2014. Berlin, Germany.

Martin SA, Coon CD, McLeod LD, Chandran A, Arnold LM. Evaluation of the fibromyalgia diagnostic screen in clinical practice. J Eval Clin Pract. 2014 Apr;20(2):158-65. doi: 10.1111/jep.12102

Elewski B, McLeod LD, Zhao Y, Mallya U, Lewbhol M. Placebo or etanercept on time to response on patient-reported psoriasis symptoms of pain, itching, and scaling (FIXTURE Study). Poster presented at the 72nd Annual Meeting of the American Academy of Dermatology; March 21, 2014.

Elewski B, McLeod LD, Zhao Y, Mallya U, Lewbhol M. Secukinumab versus placebo or etanercept on time to response on patient-reported psoriasis symptoms of pain, itching, and scaling (fixture study). Poster presented at the 72nd Annual Meeting of the American Academy of Dermatology; March 21, 2014. Denver, CO.

Hogue S, Hollis K, McLeod L, Brogan AP, Heyes A. European payer advisors' use of observational studies for health care reimbursement decisions. Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2013.

Hogue S, Scott A, van Amerongen D, Hollis K, McLeod L, Brogan A. Payer and decision maker use of observational studies for health care reimbursement decisions. Poster presented at the 2013 ISPOR 18th Annual International Meeting; April 30, 2013. [abstract] Value Health. 2013 Nov; 16(7):A459-60.

Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB, Snyder CF, Schwartz C, Revicki DA, Moinpour CM, McLeod LD, Lyons JC, Lenderking WR, Hinds PS, Hays RD, Greenhalgh J, Gershon R, Feeny D, Fayers PM, Cella D, Brundage M, Ahmed S, Aaronson NK, Butt Z. ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res. 2013 Oct;22(8):1889-905. doi: 10.1007/s11136-012-0344-y

Nelson LM, Forsythe A, McLeod L, Pulgar S, Maldonado M, Coles T, Zhang Y, Webb SM, Badia X. Psychometric evaluation of the Cushing's Quality-of-Life Questionnaire. Patient. 2013 Apr 1;Advance Online.

Coon CD, McLeod LD. Patient-reported outcomes: current perspectives and future directions. Clin Ther. 2013 Apr 1;35(4):399-401.

Fehnel S, DeMuro C, McLeod L, Coon C, Gnanasakthy A. FDA patient-reported outcome guidance: great expectations and unintended consequences. Expert Rev Pharmacoecon Outcomes Res. 2013;13(4):441-6.

Badia X, Forsythe A, Nelson LM, Coles TM, McLeod LD, Webb SM. Improvements in health-related quality of life in acromegaly with pasireotide LAR and octreotide LAR: results from a large, randomized, double-blind phase III trial. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A505.

Coon CD, Bokowy KL, Horblyuk R, Zisman RS, McLeod LD, Brown MT. The development and initial assessment of the strategy and leadership systems capability evaluation survey. Health Care Manag (Frederick). 2012 Oct 1;31(4):332-41.

Engelhart L, Nelson L, Lewis S, Mordin M, Demuro-Mercon C, Uddin S, McLeod L, Cole B, Farr J. Knee injury and osteoarthritis outcome score subscales for patients with articular cartilage lesions of the knee. Am J Sports Med. 2012 Oct 1;40(10):2264-72.

Chandran AB, Coon CD, Martin SA, McLeod LD, Coles TM, Arnold LM. Sphygmomanometry-evoked allodynia in chronic pain patients with and without fibromyalgia. Nurs Res. 2012 Sep 1;61(5):363-8.

Badia X, Roset M, Forsythe A, Coles TM, McLeod LD, Nelson LM. Clinical and patient-reported outcomes associated to pasireotide in patients with Cushing's disease. Poster presented at the 15th Annual Congress of the European Neuroendocrine Association; September 2012.

Petrillo J, Cano S, McLeod LD, Coon CD. What is the value of classical test theory, item response theory, and Rasch measurement theory in the development of patient-reported outcome instruments? Presented at the 2012 ISPOR 17th Annual International Meeting; June 2012. Washington, DC.

Martin SA, Coon CD, McLeod LD, Chandran A, Arnold L. Study of the measurement properties of the Arnold fibromyalgia diagnostic screen: results from a cross-sectional study. Presented at the 75th Annual Scientific Meeting of the American College of Rheumatology and the Association of Rheumatology Health Professionals; November 2011.

Bell C, McLeod LD, Nelson LM, Fehnel SE, Zografos LJ, Bowers B. Development and psychometric evaluation of a new patient-reported outcome instrument measuring the functional impact of insomnia. Qual Life Res. 2011 Nov 1;20(9):1457-68.

McLeod LD, Pulgar S, Nelson LM, Maldonado M, Gilligan T, Zhang Y. Psychometric evaluation of the Cushing's quality of life questionnaire (CushingQOL). Poster presented at the 18th Annual Conference of the International Society for Quality of Life Research; October 2011.

McLeod LD, Williams VS, Nelson LM, Coon CD. Psychometrics for the non-psychometrician – part I. Presented at the 18th Annual Conference of the International Society for Quality of Life Research; October 2011.

Coon CD, Nelson LM, McLeod LD, Williams VS. Psychometrics for the non-psychometrician – part II. Presented at the 18th Annual Conference of the International Society for Quality of Life Research; October 2011.

Swartz RJ, Schwartz C, Basch E, Cai L, Fairclough DL, McLeod L, Mendoza TR, Rapkin B. The king's foot of patient-reported outcomes: current practices and new developments for the measurement of change. Qual Life Res. 2011 Oct 1;20(8):1159-67.

Dalal AA, Nelson L, Gilligan T, McLeod L, Lewis S, Demuro-Mercon C. Evaluating patient-reported outcome measurement comparability between paper and alternate versions, using the lung function questionnaire as an example. Value Health. 2011 Jul 1;14(5):712-20.

Dalal AA, Nelson L, Gilligan TM, McLeod LD, Lewis SE, DeMuro C. Measurement comparability between paper and alternate versions: recommended assessment steps using the lung function questionnaire as an example. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 25, 2011. [abstract] Value Health. 2011 May; 14(3):A145.

Mintz ML, Yawn BP, Mannino DM, Donohue JF, Hanania NA, Grellet CA, Gilsenan AW, McLeod LD, Dalal AA, Raphiou IH, Prillaman BA, Crater GD, Cicale MJ, Mapel DW. Prevalence of airway obstruction assessed by lung function questionnaire. Mayo Clin Proc. 2011 May 1;86(5):375-81.

Gilligan TM, Nelson L, Dalal AA, McLeod LD. Visually evaluating the measurement comparability between paper-based and alternate versions of administration of the lung function questionnaire. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 25, 2011. [abstract] Value Health. 2011 May; 14(3):A153.

Coon CD, McLeod LD, Arnold LM, Chandran A, Martin S. Evaluating the screening ability of patient-reported outcome instruments. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 25, 2011. [abstract] Value Health. 2011 May; 14(3):A151.

Dalal A, DeMuro-Mercon CJ, Lewis SA, Nelson LM, Gilligan T, McLeod LD. Mixed modes of administration of the lung function questionnaire: validation in subjects with smoking history. Poster presented at the International Conference of the American Thoracic Society; May 2011.

McLeod LD, Coon CD, Martin SA, Fehnel SE, Hays RD. Interpreting patient-reported outcome results: uS FDA guidance and emerging methods. Expert Rev Pharmacoecon Outcomes Res. 2011 Apr 1;11(2):163-9.

Dalal AA, Demuro-Mercon C, Lewis S, Nelson L, Gilligan T, McLeod L. Validation of alternate modes of administration of the lung function questionnaire (LFQ) in subjects with smoking history. Int J Chron Obstruct Pulmon Dis. 2010 Dec 1;5:425-34.

Nelson LM, McLeod LD, Mordin MM, Farr J, Cole BJ, Uddin S, Engelhart L. Psychometric evaluation of the Knee Injury and Osteoarthritis Outcome Score (KOOS) subscales for patients with articular cartilage lesions of the knee using pilot study data of the Cartilage Autograft Implantation System (CAIS). Poster presented at the 9th World Congress of the International Cartilage Repair Society; September 2010.

Lee LJ, Fahrbach JL, Nelson LM, McLeod LD, Martin SA, Sun P, Weinstock RS. Effects of insulin initiation on patient-reported outcomes in patients with type 2 diabetes: results from the DURABLE trial. Diabetes Res Clin Pract. 2010 Aug 1;89(2):157-66.

Hollis KA, Mordin MM, Bechtel P, McLeod LD. Prospective observational studies: avoiding design pitfalls using process maps, decision-tree methods, and electronic medical records. Presented at the International Society for Pharmacoeconomics and Outcomes Research 15th Annual; May 2010.

Gilligan T, Coon C, Nelson L, McLeod L, Yang Y. Let SAS® do the work: correlation crossroads. Presented at the SAS Global Forum 2010; April 2010. Seattle, WA.

Goldberg JF, McLeod LD, Fehnel SE, Williams VSL, Hamm LR, Gilchrist K. Development and psychometric evaluation of the Bipolar Functional Status Questionnaire (BFSQ). Bipolar Disord. 2010 Feb 1;12(1):32-44.